semaglutide obstructive sleep apnea trial — a condition where breathing repeatedly stops and starts during sleep — is closely linked to obesity. New late-stage clinical results show an investigational once-weekly Lilly medicine reduced Frontiers | GLP-1/GIP dual agonist

in the context of retatrutide, these effects appear to be mitigated by the concurrent GLP-1 and GIP co-agonism observed in trials, though individual responses may vary

Q.ZhangW.LiT.YangT.YuanX.ZhouY.et al (2021a)

Serious side effects are rare but can include pancreatitis and kidney issues

Insurance and Compounded Medications The intersection of compounded medications and insurance coverage is an area of ongoing evolution: Commercial insurance: Most commercial insurance plans don't cover compounded medications

Some people do notice reduced hunger and modest changes, but the dose is primarily there to help your body adjust 3